The cut-off value of the Ki-67 index was set to 40% in our study, and the breast cancer patients with brain metastasis whose Ki-67 of ≤ 40% in the primary lesions had a longer brain metastasis-free survival compared to those whose Ki-67 of >40% in the primary lesions. The gene discussed is MKI67; the disease is breast carcinoma.